COMMUNIQUÉS West-GlobeNewswire

Galena Biopharma Reminds Shareholders to Vote Ahead of Special Meeting on December 15, 2017

08/12/2017 - 20:50

SAN RAMON, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Galena Biopharma, Inc. (NASDAQ: GALE) would like to remind stockholders to vote their respective shares and support the business combination transaction with SELLAS [...]

Burcon Announces Board Change and Confirms No Material Undisclosed Information

08/12/2017 - 18:48

VANCOUVER, British Columbia, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Burcon NutraScience Corporation (TSX: BU ) (NASDAQ: BUR ) (“Burcon” or the “Corporation”), announced that effective today, Mr. Matthew Hall has resigned as [...]

GENFIT: ADDITIONAL RESOURCES ALLOCATED TO THE LIQUIDITY AGREEMENT

08/12/2017 - 17:51

GENFIT: ADDITIONAL RESOURCES ALLOCATED TO THE LIQUIDITY AGREEMENT Lille (France), Cambridge (Massachusetts, United States), December 8, 2017 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), a biopharmaceutical company at [...]

GENFIT : APPORT COMPLEMENTAIRE AU CONTRAT DE LIQUIDITE

08/12/2017 - 17:51

GENFIT : APPORT COMPLEMENTAIRE AU CONTRAT DE LIQUIDITE Lille (France), Cambridge (Massachusetts, Etats-Unis), le 8 décembre 2017 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société biopharmaceutique engagée dans [...]

Micron Solutions, Inc. Designates Mr. E. P. Marinos as a Director Emeritus and Appoints Mr. Andrei Soran to its Board of Directors

08/12/2017 - 17:33

FITCHBURG, Mass., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Micron Solutions, Inc. (NYSE American:MICR) (“Micron” or the “Company”), announced the retirement of Mr. E. P. (“Lou”) Marinos from the Company’s Board of Directors [...]

Avivagen Announces TSX Venture Exchange Approval for Extension of Warrants

08/12/2017 - 16:51

OTTAWA, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (OTC Pink:CHEXF) (“Avivagen” or the “Company”), a life sciences innovation company with a series of patent protected products that support and optimize [...]

American Health Council Honors Julio C. Soto, MD as “Best in Medicine”

08/12/2017 - 16:46

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- The American Health Council honors Julio C. Soto, MD as “Best in Medicine” for his wealth of medical expertise and commitment to increased patient autonomy over their medical [...]

Akers Biosciences Secures Further Intellectual Property Protection for Akers Wellness Line

08/12/2017 - 16:31

THOROFARE, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Akers Biosciences, Inc. (NASDAQ: AKER) (AIM: AKR.L), (“Akers Bio” or the "Company"), a developer of rapid health information technologies, announces that its Health and [...]

Medifirst Solutions Announces Shareholder Update

08/12/2017 - 16:30

Freehold, NJ , Dec. 08, 2017 (GLOBE NEWSWIRE) -- MEDIFIRST SOLUTIONS, INC. (OTC: MFST) (the “Company” or “Medifirst”), a provider of innovative laser technology with its FDA 510(k) cleared Infrared Time Machine TTML- [...]

Oxford Performance Materials Sells Aerospace & Defense Business to Strategic Investor Hexcel Corporation

08/12/2017 - 15:15

SOUTH WINDSOR, Conn., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Oxford Performance Materials, Inc. (OPM), a leader in advanced materials science and high performance additive manufacturing (HPAM™), today announced that it has [...]

Biohit Oyj’s Financial Reporting and Annual General Meeting in 2018

08/12/2017 - 15:00

Biohit Oyj Financial calendar, December 8, 2017 at 4:00 pm local time (EET) Biohit Oyj will release its financial statements for 2017 on Wednesday 28 th of February 2018 at 9:30 am. The Annual Report, which contains the [...]

Asklepion Pharmaceuticals Presents Phase 1b/2a Clinical Trial Data for IV-Citrulline at the Pediatric Cardiac Intensive Care Society 13th Annual International Meeting

08/12/2017 - 15:00

BALTIMORE, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Asklepion Pharmaceuticals, LLC (“Asklepion” or “the Company”), a biotechnology company focused on the development of IV-citrulline for rare pediatric diseases, announced [...]

Cancer Genetics Prices $7 Million Registered Direct Offering

08/12/2017 - 14:58

RUTHERFORD, N.J., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq: CGIX ), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, today announced the pricing of a [...]

Fennec Announces Pricing of Public Offering

08/12/2017 - 14:54

RESEARCH TRIANGLE PARK, N.C., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a biotechnology company focused on the development of PEDMARK TM (a unique formulation of sodium [...]

Marrone Bio Innovations Announces the Availability of Amplitude™ Biofungicide for White Mold Control in the 2018 Growing Season

08/12/2017 - 14:30

DAVIS, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII ) (MBI), a leading provider of bio-based pest management and plant health products for agriculture, turf and ornamental and [...]

TG Therapeutics, Inc. Recaps Data Presentations at the Upcoming 59th American Society of Hematology Annual Meeting

08/12/2017 - 14:06

NEW YORK, Dec. 08, 2017 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX ), today recapped the schedule of data presentations for the Company’s lead compounds, TGR-1202, (umbralisib), the Company's once-daily [...]

Allscripts hits record-breaking 1 billion API data shares in a single year

08/12/2017 - 14:01

CHICAGO, Dec. 08, 2017 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX ) continues to lead the industry in innovation, interoperability, data sharing, and connectivity as it hits an industry leading milestone of one [...]

Aeterna Zentaris Announces Departure of Interim Chief Financial Officer

08/12/2017 - 14:00

CHARLESTON, S.C., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) (the “Company”) announced today the departure of the Company’s Interim Chief Financial Officer, Jeffrey Whitnell, [...]

Soleno Therapeutics Announces Joint Venture Agreement for Development and Commercialization of CoSense Monitoring Technology

08/12/2017 - 14:00

REDWOOD CITY, Calif., Dec. 08, 2017 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (NASDAQ: SLNO ), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today [...]